Stent thrombosis in patients with drug‑‑eluting stents and bioresorbable vascular scaffolds: the feared complication.
The percutaneous coronary intervention (PCI) has undergone rapid evolution over the last 40 years and has become one of the most widely performed medical procedures. The introduction of intracoronary stents has improved the safety and efficacy of PCI. However, with the advent of stenting, a new potentially fatal enemy has emerged: stent thrombosis. Ever since, adjunct pharmacological therapy, stent technique, and technology have been adjusted to reduce the risk of stent thrombosis. The aim of the present article is to provide an overview of the past, present, and future aspects of PCI in relation to stent thrombosis.